๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

PGI1 Acne Drug Therapy and the Development of Comorbid Inflammatory Bowel Disease in the United States

โœ Scribed by Lin, H.C.; Lee, C.H.; Balkrishnan, R.; Feldman, S.R.

Book ID
122210916
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
53 KB
Volume
15
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Drug development in inflammatory bowel d
Drug development in inflammatory bowel disease: The role of the FDA
โœ Conor Lahiff; Sunanda Kane; Alan C. Moss ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 198 KB ๐Ÿ‘ 2 views

All medicinal compounds sold in the United States for inflammatory bowel disease (IBD) are regulated by the Food and Drug Administration (FDA) via a number of regulations dating back to 1906. The primary contemporary role of the FDA is in the assessment of safety and efficacy, and subsequent marketi

Hospitalizations for inflammatory bowel
Hospitalizations for inflammatory bowel disease: Profile of the uninsured in the United States
โœ Geoffrey C. Nguyen; Justina Sam; Sanjay K. Murthy; Gilaad G. Kaplan; Jill M. Tin ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 225 KB ๐Ÿ‘ 1 views

## Background: Inflammatory bowel disease (ibd) patients may be at increased risk for having no health insurance. our objectives were to assess the prevalence of hospitalized ibd patients without insurance in the us and to characterize predictive factors. ## Methods: We identified ibd admissions